Literature DB >> 22039144

A European perspective--the European clinical research infrastructures network.

J Demotes-Mainard1, C Kubiak.   

Abstract

Evaluating research outcomes requires multinational cooperation in clinical research for optimization of treatment strategies and comparative effectiveness research, leading to evidence-based practice and healthcare cost containment. The European Clinical Research Infrastructures Network (ECRIN) is a distributed ESFRI (European Strategy Forum on Research Infrastructures) roadmap pan-European infrastructure designed to support multinational clinical research, making Europe a single area for clinical studies, taking advantage of its population size to access patients, and unlocking latent scientific potential. Servicing multinational trials started during its preparatory phase, and ECRIN will now apply for an ERIC (European Research Infrastructures Consortium) status by 2011. By creating a single area for clinical research in Europe, this achievement will contribute to the implementation of the Europe flagship initiative 2020 'Innovation Union', whose objectives include defragmentation of the research and education capacity, tackling the major societal challenges starting with the area of healthy ageing, and removing barriers to bring ideas to the market.

Entities:  

Mesh:

Year:  2011        PMID: 22039144     DOI: 10.1093/annonc/mdr425

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  6 in total

Review 1.  A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome?

Authors:  Ana Rath; Valérie Salamon; Sandra Peixoto; Virginie Hivert; Martine Laville; Berenice Segrestin; Edmund A M Neugebauer; Michaela Eikermann; Vittorio Bertele; Silvio Garattini; Jørn Wetterslev; Rita Banzi; Janus C Jakobsen; Snezana Djurisic; Christine Kubiak; Jacques Demotes-Mainard; Christian Gluud
Journal:  Trials       Date:  2017-11-22       Impact factor: 2.279

2.  An investigation into the factors affecting investigator-initiated trial start-up in Ireland.

Authors:  Lauren Leddy; Prasanth Sukumar; Lydia O'Sullivan; Fionnuala Keane; Declan Devane; Peter Doran
Journal:  Trials       Date:  2020-11-23       Impact factor: 2.279

Review 3.  Specific barriers to the conduct of randomised clinical trials on medical devices.

Authors:  Edmund A M Neugebauer; Ana Rath; Sunya-Lee Antoine; Michaela Eikermann; Doerthe Seidel; Carsten Koenen; Esther Jacobs; Dawid Pieper; Martine Laville; Séverine Pitel; Cecilia Martinho; Snezana Djurisic; Jacques Demotes-Mainard; Christine Kubiak; Vittorio Bertele; Janus C Jakobsen; Silvio Garattini; Christian Gluud
Journal:  Trials       Date:  2017-09-13       Impact factor: 2.279

Review 4.  Barriers to the conduct of randomised clinical trials within all disease areas.

Authors:  Snezana Djurisic; Ana Rath; Sabrina Gaber; Silvio Garattini; Vittorio Bertele; Sandra-Nadia Ngwabyt; Virginie Hivert; Edmund A M Neugebauer; Martine Laville; Michael Hiesmayr; Jacques Demotes-Mainard; Christine Kubiak; Janus C Jakobsen; Christian Gluud
Journal:  Trials       Date:  2017-08-01       Impact factor: 2.279

Review 5.  Evidence-based practice within nutrition: what are the barriers for improving the evidence and how can they be dealt with?

Authors:  Martine Laville; Berenice Segrestin; Maud Alligier; Cristina Ruano-Rodríguez; Lluis Serra-Majem; Michael Hiesmayr; Annemie Schols; Carlo La Vecchia; Yves Boirie; Ana Rath; Edmund A M Neugebauer; Silvio Garattini; Vittorio Bertele; Christine Kubiak; Jacques Demotes-Mainard; Janus C Jakobsen; Snezana Djurisic; Christian Gluud
Journal:  Trials       Date:  2017-09-11       Impact factor: 2.279

6.  The Translational Medicine Professional: A Bridge Between Bench and Bedside?

Authors:  Faekah Gohar; Aisha Gohar; Georg Hülskamp; Otfried Debus
Journal:  Front Med (Lausanne)       Date:  2018-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.